
Congress trades
Amedisys, Inc. (AMED)
NASDAQ · Healthcare · 5 congress trades · last filed 1 year agono longer trading under this ticker
About Amedisys, Inc.
from the company's filings and listing, as of Oct 21, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- -
- Employees
- 19,000
- Listed since
- Aug 17, 1994
- Market value
- $3.3Blast quoted Aug 14, 2025
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2025reported Jul 29, 2025 | $1.54 | $1.39 | $621.9M | $635.8M | EPS beatRevenue miss |
| Q1 FY2025reported Apr 23, 2025 | $1.25 | $1.13 | $594.8M | $612.0M | EPS beatRevenue miss |
| Q4 FY2024reported Feb 26, 2025 | $0.96 | $1.05 | $598.1M | $602.4M | EPS missRevenue in line |
| Q3 FY2024reported Nov 6, 2024 | $1.00 | $1.17 | $587.7M | $596.4M | EPS missRevenue in line |
| Q2 FY2024reported Jul 24, 2024 | $1.32 | $1.22 | $591.2M | $578.8M | EPS beatRevenue beat |
| Q1 FY2024reported Apr 24, 2024 | $1.03 | $1.01 | $571.4M | $565.4M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Congress trades in AMED
5 disclosures of 5 on record · median 25d of the 45 allowedSince the trade: the stock's move from the trade date to the last close under this ticker (Aug 14, 2025), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | n/a | Aug 18, 2025 | Sep 12, 2025 | 25d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +7.2%S&P 500 +7.6% · -0.4 pts vs S&P 500 | Jun 9, 2025 | Aug 13, 2025 | 65d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +27.9%After the saleS&P 500 +64.7% · -36.8 pts vs S&P 500 | Mar 14, 2023 | Apr 7, 2023 | 24d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +4.6%S&P 500 +58.1% · -53.5 pts vs S&P 500 | Feb 10, 2023 | Mar 3, 2023 | 21d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +23.9%S&P 500 +63.1% · -39.2 pts vs S&P 500 | Jan 11, 2023 | Feb 7, 2023 | 27d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in AMED, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded AMED?
Lisa C. McClain and Ro Khanna disclosed AMED transactions in the filings shown here.
How quickly are AMED trades disclosed?
Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
